Document is current
Any future updates will be listed below
-
Authors
Gleitz, Hélène FE https://orcid.org/0000-0001-6138-8916
Liao, Ai Yin
Cook, James R https://orcid.org/0000-0002-1905-4928
Rowlston, Samuel F
Forte, Gabriella MA
D'Souza, Zelpha
O'Leary, Claire
Holley, Rebecca J
Bigger, Brian W https://orcid.org/0000-0002-9708-1112
-
Funding
Funding for this research was provided by:
BBSRC
Wellcome Trust
University of Manchester Strategic Fund
The Isaac Foundation
Newlife Foundation for Disabled Children (14‐15/22)
National Mucopolysaccharidosis Society (MPSII research grant 2015)
- License Information
-
More Information
Article History
Received: 29 November 2017
Revised: 10 May 2018
Accepted: 16 May 2018
First Online: 8 June 2018
Conflict of interest
: HFEG and BWB are co‐inventors on a patent application (GB1701968.8) for the use of IDS.ApoEII for the treatment of MPS II.
